By Sabela Ojea
Mustang Bio is exiting the lease for its manufacturing facility in Worcester, Mass., and selling some fixed assets from the plant for $1 million.
The clinical-stage biopharmaceutical company on Thursday said that the divestment includes selling furniture and equipment to AbbVie Bioresearch, located in the same city.
As a result of the termination of the lease, Mustang Bio expects savings of about $2 million of cash expenses over the next 24 months.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
February 27, 2025 17:33 ET (22:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。